The interleukin-6-174 G/C promoter polymorphism and arterial stiffness; the Rotterdam study

Vascular Health and Risk Management

Volumn 4, Issue 4, 2008, Pages 863-869

  Sie, Mark P S ^a   Mattace Raso, Francesco U S ^a   Uitterlinden, André G ^a   Arp, Pascal P ^a   Hofman, Albert ^a   Pols, Huibert A P ^a   Hoeks, Arnold P G ^b   Reneman, Robert S ^b   Asmar, Roland ^c   van Duijn, Cornelia M ^a   Witterman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Cardiovascular Institute   (France)

Author keywords

Arterial stiffness; CRP; Distensibility coefficient; IL 6; Pulse pressure; Pulse wave velocity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGE; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE; HOMOZYGOTE; HUMAN; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POPULATION RESEARCH; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; WILD TYPE;

AGED; ARTERIES; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ELASTICITY; FEMALE; HOMOZYGOTE; HUMANS; INTERLEUKIN-6; MALE; NETHERLANDS; PHENOTYPE; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES;

EID: 52249105964     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Abramson JL, Weintraub WS, Vaccarino V. 2002. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension, 39:197-202.
2. Avolio AP, Chen SG, Wang RP, et al. 1983. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation, 68:50-8.
3. Basso F, Lowe GD, Rumley A, et al. 2002. Interleukin-6 -174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol, 22:599-604.
4. Benetos A, Safar M, Rudnichi A, et al. 1997. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension, 30:1410-15.
5. Bennermo M, Held C, Green F, et al. 2004. Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis, 174:157-63.
6. Bennet AM, Prince JA, Fei GZ, et al. 2003. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis, 171:359-67.
7. Bots ML, Hoes AW, Koudstaal PJ, et al. 1997. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 96:1432-7.
8. Buts ML, Mulder PG, Hofman A, et al. 1994. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol, 47:921-30.
9. Boutouyrie P, Tropeano AI, Asmar R, et al. 2002. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension, 39:10-5.
10. Brull DJ, Montgomery HE, Sanders J, et al. 2001. Interleukin-6 gene -174g > c and -572g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol, 21:1458-63.
11. Bruunsgaard H, Christiansen L, Pedersen AN, et al. 2004. The IL-6 -174G>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans. Exp Gerontol, 39:255-61.
12. Castell JV, Gomez-Lechon MJ, David M, et al. 1990. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology, 12:1179-86.
13. [DCDM] Expert Committee on the Diagnosis and Classficiation of Diabetes Mellitus. 1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20:1183-97.
14. Diamant M, Lamb HJ, van de Ree MA, et al. 2005. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab, 90:1495-501.
15. Fishman D, Faulds G, Jeffery R, et al. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102:1369-76.
16. Franklin SS, Khan SA, Wong ND, et al. 1999. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation, 100:354-60.
17. Girerd X, Mourad JJ, Copie X, et al. 1994. Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens, 7:1076-84.
18. Heinrich PC, Castell JV and Andus T. 1990. Interleukin-6 and the acute phase response. Biochem J, 265:621-36.
19. Hoeks AP, Brands PJ, Smeets FA, et al. 1990. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol, 16:121-8.
20. Hoftnan A, Grobbee DE, de Jong PT, et al. 1991. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol, 7:403-22.
21. Jenny NS, Tracy RP, Ogg MS, et al. 2002. In the elderly, interleukin-6 plasma levels and the -174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol, 22:2066-71.
22. Kool MJ, van Merode T, Reneman RS, et al. 1994. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res, 28:610-14.
23. Kullo IJ, Seward JB, Bailey KR, et al. 2005. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens, 18:1123-9.
24. Lieb W, Pavlik R, Erdmann J, et al. 2004. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol, 97:205-12.
25. London GM, Marchais SJ, Safar ME, et al. 1990. Aortic and large artery compliance in end-stage renal failure. Kidney Int, 37:137-42.
26. Mahmud A and Feely J. 2005. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension, 46:1118-22.
27. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. 2006. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation, 113:657-63.
28. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, et al. 2004. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis, 176:111-16.
29. Nabata T, Morimoto S, Koh E, et al. 1990. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int, 20:445-53.
30. Nauck M, Winkelmann BR, Hoffmann MM, et al. 2002. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med, 80:507-13.
31. Riches P, Gooding R, Millar BC, et al. 1992. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods, 153:125-31.
32. Roman MJ, Saba PS, Pini R, et al. 1992. Parallel cardiac and vascular adaptation in hypertension. Circulation, 86:1909-18.
33. Sayed-Tabatabaei FA, van Rijn MJ, Schut AF, et al. 2005. Heritability of the function and structure of the arterial wall: findings of the Erasmus Rucphen Family (ERF) study. Stroke, 36:2351-6.
34. Sie MP, Sayed-Tabatabaci FA, Oei HH, et al. 2006. Interleukin 6-174 G/C promoter polymorphism and risk of coronary heart disease. Results from the Rotterdam Study and a meta-analysis. Arterioscler Thromb Vasc Biol, 26:212-17.
35. Tomiyama H, Koji Y, Yambe M, et al. 2005. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension, 45:997-1003.
36. van Popele NM, Grobbee DE, Buts ML, et al. 2001. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke, 32:454-60.
37. Vickers MA, Green FR, Terry C, et al. 2002. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res, 53:1029-34.
38. Vlachopoulos C, Dima I, Aznaouridis K, et al. 2005. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation, 112:2193-200.
39. Waage A, Brandtzaeg P, Halstensen A, et al. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med, 169:333-8.
40. Wada T, Kodaira K, Fujishiro K, et al. 1994. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler Thromb, 14:479-82.
41. Waddell TK, Dart AM, Medley TL, et al. 2001. Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension, 38:927-31.
42. Witteman JC, Grobbee DE, Valkenburg HA, et al. 1994. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet, 343:504-7.
43. Yudkin JS, Stehouwer CD, Emeis JJ, et al. 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol, 19:972-8.